Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Scopus BioPharma Inc. (SCPS) had Return on Equity of 27.88% for the most recently reported fiscal quarter, ending 2023-06-30.
| Income Statement Financials | |
-- |
|
$-2.62M |
|
-- |
|
-- |
|
$2.93M |
|
$-2.93M |
|
-- |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
39.74M |
|
39.74M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$0.50M |
|
$0.00M |
|
$0.00M |
|
$0.50M |
|
$11.00M |
|
-- |
|
-- |
|
$11.00M |
|
$-10.50M |
|
$-10.50M |
|
$-10.50M |
|
39.78M |
|
| Cash Flow Statement Financials | |
$-1.77M |
|
-- |
|
$1.97M |
|
$0.12M |
|
$0.36M |
|
$0.24M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
27.88% |
27.88% |
|
-588.65% |
|
27.88% |
|
$-0.26 |
|
$-0.04 |
|
$-0.04 |
|